SCHEMBL3472325

SCHEMBL3472325

Cc1nn(CCCl)c(C)c1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLS O94925 1/20 0.68
ALDH1A1 P00352 4/20 0.66
CYP1A1 P04798 1/20 0.46
KMT2A Q03164 3/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ATM Q13315 2/20 0.35
KDM4E B2RXH2 1/20 0.34
MAPT P10636 2/20 0.33
MEN1 O00255 2/20 0.33
MAPK1 P28482 2/20 0.33
USP2 O75604 1/20 0.33
POLB P06746 1/20 0.33
HSP90AA1 P07900 1/20 0.33
TSHR P16473 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
GAA P10253 1/20 0.33
GFER P55789 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13180563 0.77 GLS (0.61) GLSALDH1A1CYP1A1KMT2AL3MBTL1
SCHEMBL8657294 0.76 GLS (0.59) GLSALDH1A1CYP1A1KMT2AL3MBTL1
SCHEMBL11185742 0.75 GLS (0.58) GLSALDH1A1CYP1A1KMT2AL3MBTL1
SCHEMBL11170688 0.71 GLS (0.53) GLSALDH1A1CYP1A1KMT2AL3MBTL1
SCHEMBL1745199 0.70 ALDH1A1 (0.39) GLSALDH1A1ATMMAPTGAA
SCHEMBL111808 0.69 ALDH1A1 (0.67) GLSALDH1A1CYP1A1KMT2AL3MBTL1
SCHEMBL1196791 0.69
SCHEMBL13024308 0.65 TSHR (0.49) GLSALDH1A1KMT2AATMMAPT
SCHEMBL11753456 0.64 GLS (0.42) GLSALDH1A1KDM4EPOLBLMNA
SCHEMBL11186176 0.64 GLS (0.45) GLSALDH1A1CYP1A1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100105663-A1 2-(HETEROARYL) ALKYL INDAZOLE 6-PHENYL AND THIENYL METHYL AMIDE AS THROMBIN INHIBITORS BAYER HEALTHCARE AG (DE) 2010-04-29 US disclosed
EP-2044031-A1 2-(HETEROARYL) ALKYL INDAZOLE 6-PHENYL AND THIENYL METHYL AMIDE AS THROMBIN INHIBITORS Bayer HealthCare AG (DE) 2009-04-08 EP disclosed
WO-2008006479-A1 2-(HETEROARYL) ALKYL INDAZOLE 6-PHENYL AND THIENYL METHYL AMIDE AS THROMBIN INHIBITORS BAYER HEALTHCARE AG (DE) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105663-A1 2-(HETEROARYL) ALKYL INDAZOLE 6-PHENYL AND THIENYL METHYL AMIDE AS THROMBIN INHIBITORS F2, TFPI, PLAT GLS 1420/4885ALDH1A1 2776/4885CYP1A1 151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.